Impact of COVID-19 on access to cancer care in Rwanda: a retrospective time-series study using electronic medical records data.
Placide HabinshutiAlphonse NshimyiryoDonald Luke FejfarAnne NiyigenaVincent K CubakaNadine KaremaJean Bosco BigirimanaCyprien ShyirambereDale A BarnhartFredrick KateeraIsabel Fulchernull nullPublished in: BMJ open (2022)
Although scheduling procedures for visits continued as expected, our findings reveal that the COVID-19 pandemic interrupted patients' ability to access cancer care and attend scheduled appointments at the BCCOE. This interruption in care suggests delayed diagnosis and loss to follow-up, potentially resulting in a higher rate of negative health outcomes among cancer patients in Rwanda.
Keyphrases
- healthcare
- end stage renal disease
- coronavirus disease
- newly diagnosed
- public health
- sars cov
- ejection fraction
- chronic kidney disease
- palliative care
- prognostic factors
- genome wide
- quality improvement
- machine learning
- single cell
- gene expression
- dna methylation
- patient reported outcomes
- chronic pain
- human health
- social media